RESCOM

ResCom,® a unique operating division within our DSM Pharma Chemicals unit, is specifically dedicated to providing manufacturing services for early phase development projects. Comprised of approximately 40 researchers in state-of-the-art laboratories and a mini-plant based in Regensburg, Germany, this team has built a long-standing record of supplying quality advanced intermediates and APIs for preclinical and early phase programs.

In addition to its strong scientific and professional staff, ResCom® has entered into strategic partnerships with Syncom and Chiralix. Both companies, based in The Netherlands, are experienced contract research organizations that offer  DSM’s customers specialized services such as organic synthesis, organo-metallic catalysis and biocatalysis. These strategic partnerships help ResCom® develop flexible synthetic routes to chiral “drug-like” building blocks such as densely functionalized non-proteinogenic amino acids.

What else does ResCom® offer?

Focus on specialized needs of both emerging pharmaceutical companies and large multinational firms

An entrepreneurial approach for the reliable execution of your projects

20-year track record of performance and quality

Broad technology base

Rapid implementation from lab to mini-plant

Chemical manufacturing services from kg to pilot scale

Seamless project transfer from pilot to commercial scale cGMP facilities

Responsive and Committed